Guiding Management of Bethesda V Thyroid Nodules: The Role of Molecular Testing
Our findings suggest that molecular profiling offers insights into risk stratification for Bethesda V thyroid lesions, demonstrating a very low incidence of aggressive pathology in the low-risk molecular group.
Authors
- Idit Tessler (ORCID: https://orcid.org/0000-0002-3297-7022)
- Richard J. Payne (ORCID: https://orcid.org/0000-0003-3987-8243)
- Grégoire B. Morand (ORCID: https://orcid.org/0000-0002-6150-6772)
- Eran E. Alon (ORCID: https://orcid.org/0000-0002-2981-6092)
- Arad Dotan (ORCID: https://orcid.org/0000-0002-3300-3676)
- Nir A. Gecel (ORCID: https://orcid.org/0000-0002-3468-3191)
- Galit Avior (ORCID: https://orcid.org/0000-0002-6716-8671)
- Tzahi Yamin (ORCID: https://orcid.org/0000-0002-6252-3646)
Institutions
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
- Jewish General Hospital (CA)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- Clinical Endocrinology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1111/cen.70032
- Citations
- 1
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.29